scholarly article | Q13442814 |
P50 | author | Claire Rome | Q57617379 |
Corinne Albiges-Rizo | Q64681294 | ||
Eva Faurobert | Q68223379 | ||
Daniel Bouvard | Q88421789 | ||
Justyna Lisowska | Q90374900 | ||
Sandra Manet-Dupé | Q114408106 | ||
Anne-Pascale Bouin | Q114408107 | ||
Gwénola Boulday | Q42187601 | ||
Elisabeth Tournier-Lasserve | Q42187629 | ||
Jean-Luc Coll | Q56384222 | ||
Martial Balland | Q57452281 | ||
P2093 | author name string | Florence Ruggiero | |
Marilyne Malbouyres | |||
Michelle Kéramidas | |||
P2860 | cites work | Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1 | Q24296474 |
CCM1 regulates vascular-lumen organization by inducing endothelial polarity | Q24304408 | ||
ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin | Q24308783 | ||
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis | Q24309334 | ||
Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1 alpha | Q24324657 | ||
Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis | Q24338343 | ||
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells | Q24654323 | ||
Mechanism for KRIT1 Release of ICAP1-Mediated Suppression of Integrin Activation | Q27675893 | ||
Integrins: bidirectional, allosteric signaling machines | Q27860700 | ||
Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway | Q28116174 | ||
KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis | Q28202423 | ||
Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation | Q28210519 | ||
KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions | Q28254336 | ||
Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype | Q28274176 | ||
Cell adaptive response to extracellular matrix density is controlled by ICAP-1-dependent beta1-integrin affinity | Q28507546 | ||
Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions | Q28575990 | ||
Cell adhesion: integrating cytoskeletal dynamics and cellular tension | Q29618066 | ||
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells | Q29619848 | ||
Fibronectins, their fibrillogenesis, and in vivo functions | Q30421926 | ||
Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation | Q30492193 | ||
Cell-ECM traction force modulates endogenous tension at cell-cell contacts. | Q30499136 | ||
The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins. | Q30500836 | ||
Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition | Q30502880 | ||
Spatial organization of the extracellular matrix regulates cell-cell junction positioning. | Q30505114 | ||
Assembly of Fibronectin Extracellular Matrix | Q30538938 | ||
Unraveling ICAP-1 function: toward a new direction? | Q33236980 | ||
Second harmonic generation confocal microscopy of collagen type I from rat tendon cryosections | Q33264767 | ||
Defective osteoblast function in ICAP-1-deficient mice | Q33287597 | ||
Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction | Q33348515 | ||
Mechanosensing in actin stress fibers revealed by a close correlation between force and protein localization | Q33436122 | ||
Control of cell adhesion dynamics by Rap1 signaling | Q33740476 | ||
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity | Q33794968 | ||
Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype | Q33811092 | ||
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia | Q34021937 | ||
Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice | Q34209951 | ||
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. | Q34424235 | ||
Binding of soluble fibronectin to integrin alpha5 beta1 - link to focal adhesion redistribution and contractile shape. | Q34793769 | ||
Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization | Q34822720 | ||
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases | Q34924413 | ||
Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations. | Q35119689 | ||
Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism | Q35227393 | ||
Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations | Q35463131 | ||
Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis | Q35628173 | ||
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease | Q35693325 | ||
Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice. | Q35911222 | ||
Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity | Q36237442 | ||
Signaling mechanisms regulating endothelial permeability | Q36350076 | ||
The role of extracellular matrix in vascular branching morphogenesis | Q36542074 | ||
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases | Q57912086 | ||
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen | Q67675651 | ||
Monoclonal Antibody 9EG7 Defines a Novel β1 Integrin Epitope Induced by Soluble Ligand and Manganese, but Inhibited by Calcium | Q71823689 | ||
Down regulation of talin alters cell adhesion and the processing of the alpha 5 beta 1 integrin | Q71825269 | ||
A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly | Q73807660 | ||
The matrix reorganized: extracellular matrix remodeling and integrin signaling | Q36571065 | ||
Fibronectin fibrillogenesis regulates three-dimensional neovessel formation | Q36585500 | ||
Balancing forces: architectural control of mechanotransduction | Q36588911 | ||
Dynamic and label-free cell-based assays using the real-time cell electronic sensing system | Q36658140 | ||
Cell traction forces direct fibronectin matrix assembly | Q37277062 | ||
Adhesion signaling - crosstalk between integrins, Src and Rho. | Q37429375 | ||
Permanent cell line expressing human factor VIII-related antigen established by hybridization | Q37615209 | ||
Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. | Q37680004 | ||
Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis | Q37709678 | ||
Spatial organization of adhesion: force-dependent regulation and function in tissue morphogenesis | Q37780682 | ||
Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution | Q37784507 | ||
Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. | Q37902604 | ||
β1-integrin: a potential therapeutic target in the battle against cancer recurrence | Q37928830 | ||
Spatial segregation between cell-cell and cell-matrix adhesions | Q38033861 | ||
A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels. | Q39552355 | ||
Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin | Q40069445 | ||
Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. | Q40714956 | ||
Interaction of the integrin beta1 cytoplasmic domain with ICAP-1 protein | Q40985640 | ||
Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations | Q42187240 | ||
Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces | Q42212876 | ||
A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. | Q42238933 | ||
Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. | Q42250384 | ||
Krit1 modulates beta 1-integrin-mediated endothelial cell proliferation | Q45787726 | ||
Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability | Q46803220 | ||
Proteomic identification of the cerebral cavernous malformation signaling complex | Q46978413 | ||
Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. | Q48017009 | ||
Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. | Q52539441 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P1104 | number of pages | 17 | |
P304 | page(s) | 545-561 | |
P577 | publication date | 2013-08-01 | |
P1433 | published in | Journal of Cell Biology | Q1524550 |
P1476 | title | CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling | |
P478 | volume | 202 |
Q35876785 | ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis |
Q34076187 | Alternative splicing of endothelial fibronectin is induced by disturbed hemodynamics and protects against hemorrhage of the vessel wall |
Q38824364 | Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies. |
Q42615679 | CCM proteins control endothelial β1 integrin dependent response to shear stress |
Q38203137 | CCM1 and the second life of proteins in adhesion complexes. |
Q28650415 | CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation |
Q37618688 | Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration |
Q92853858 | Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation |
Q28072671 | Cerebral Cavernous Malformations: Review of the Genetic and Protein-Protein Interactions Resulting in Disease Pathogenesis |
Q37583343 | Cerebral cavernous malformation proteins at a glance. |
Q57456322 | Cerebrovascular disorders associated with genetic lesions |
Q34112722 | Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling |
Q35047913 | Endothelial destabilization by angiopoietin-2 via integrin β1 activation. |
Q38630594 | Endothelial fluid shear stress sensing in vascular health and disease. |
Q99211437 | EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity |
Q38991274 | Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis. |
Q64053576 | Fibronectin inhibitor pUR4 attenuates tumor necrosis factor α-induced endothelial hyperpermeability by modulating β1 integrin activation |
Q48175918 | Heg1 and Ccm1/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis. |
Q30373402 | Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements |
Q37351147 | Introduction to cerebral cavernous malformation: a brief review |
Q30278010 | KLF4 is a key determinant in the development and progression of cerebral cavernous malformations |
Q90568063 | KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction |
Q61813848 | KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced -Glutathionylation of Distinct Structural and Regulatory Proteins |
Q34552843 | KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling |
Q48127718 | Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus. |
Q33605599 | Opposing effects of collagen I and vitronectin on fibronectin fibril structure and function |
Q38957623 | Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin. |
Q38182363 | Protein conformation as a regulator of cell-matrix adhesion |
Q38196358 | Regulation of the endothelial barrier function: a filum granum of cellular forces, Rho-GTPase signaling and microenvironment. |
Q37705440 | STRIPAK components determine mode of cancer cell migration and metastasis. |
Q89473543 | Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation |
Q37722299 | Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. |
Q28607249 | Structural analysis of the KRIT1 ankyrin repeat and FERM domains reveals a conformationally stable ARD-FERM interface |
Q58764066 | Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations |
Q45896703 | The CCM complex puts a cap on integrin activity |
Q38717133 | The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers |
Q90319459 | Vis-à-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis |
Search more.